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Abstract
Background -  The percentage of patients 
inhaling their medication effectively varies 
widely, according to methods of assess­
ment and inhalers used. This study was 
carried out to assess differences among 
four types of inhalers using inhaler- 
specific checklists.
Methods -  Inhalation technique was eval­
uated in adult patients with chronic ob­
structive pulmonary disease (COPD). 
Inhalers investigated were either metered 
dose inhalers (MDIs) or the dry powder 
inhalers Turbohaler (Turbuhaler), Disk- 
haler, and Rotahaler. Errors were re­
corded against inhaler-specific checklists. 
From these, scores were derived by di­
viding the number of items correctly com­
pleted by the total number of items on the 
checklist and the result was expressed as 
a percentage. For every inhaler “essential 
actions55 were identified and scores on 
these key manoeuvres were calculated. 
The percentage of patients performing all 
these essential actions correctly was also 
calculated. Scores were also compared 
with adjustment for differences in relevant 
patient characteristics.
Results -  Important differences among 
inhalers were found. Of 152 patients with 
COPD (mean (SD) age 55-1 (8*7) years), 
those with MDIs performed worst, espe­
cially when only essential items were con­
sidered. Patients with a Diskhaler did best, 
although after correction for patient char­
acteristics the differences tended to di­
minish. Only 60% of patients were able to 
perform all essential inhaler actions sat­
isfactorily. Of those using the Diskhaler, 
96% did so correctly, while the cor­
responding figure for those using the MDI 
was only 24%.
Conclusions -  Many patients with COPD 
use their inhaler ineffectively. After ad­
justing for patient characteristics, differ­
ences among inhalers, although less 
pronounced, persist. Patients using a 
Diskhaler made fewest errors, while 
most patients using MDIs made crucial 
mistakes.
( Thorax 1995;50:1183-1187)
Keywords: inhaler3 administration chronic obstructive 
pulmonary disease3 inhalation technique.
Inhaled medication plays an important part in 
the treatment of asthma and chronic ob­
structive pulmonary disease (COPD). In the 
Netherlands two types of inhaler are in com­
mon use; metered dose inhalers (MDIs) and 
(in the majority) dry powder inhalers (DPIs). 
Both have their advantages and disadvantages. 
MDIs are small, easy to carry* and deliver at 
least 100 doses* but they require good hand- 
lung coordination to achieve the best results,1 
DPIs* being breath actuated* are unaffected by 
hand-lung coordination* but patients need an 
inspiratory flow ofmorethan301/minute which 
might prove difficult to achieve for patients 
with severe COPD.
The percentage of patients inhaling their 
medication effectively varies from 2% to 85% 
according to the method of assessment and 
the type of inhaler.2“11 A previous survey of 
inhalation technique in 123 patients with 
COPD12 revealed that one third failed to use 
their inhaler effectively* and that inhaler- 
specific design features contributed sig­
nificantly to the failure rate. The latter finding 
is confirmed in a number of other reports.13-15
To our knowledge* no comparable study of 
inhaler technique has considered such patient 
variables as age* sex* educational achievement* 
type of health care insurance* duration of dis­
ease* previous experience with the inhaler* or 
instruction in inhalation technique* all of which 
may influence the efficacy of treatment. In two 
studies an attempt was made to obviate these 
difficulties by means of a crossover design* but 
in both the patient sample was small (32 and
36 subjects) and the duration of follow up 
limited one and two months* respectively,1315
This paper assesses differences among four 
different inhalation devices in relation to 
patient characteristics in a large sample of 
patients who have been using medication for a 
long time.
Methods
All patients with COPD aged between 18 and 
65 years who attended the pulmonary out­
patient department between February and June 
1994 were included in the study. Those who 
had used inhaled medication for less than one 
month or with a limited ability to understand 
and speak Dutch were excluded. The re­
mainder* a total of 152 individuals* formed the 
sample from whom the results were obtained. 
The inhalers investigated were MDIs and three 
dry powder devices (Turbohaler (Turbuhaler)* 
Diskhaler* and Rotahaler), Other inhalers (for 
example, Autohaler, Spinhaler) and large vol­
ume spacers are seldom used in our department 
and therefore were not included in the study.
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Table 1 Inhaler-specific checklists with items scores
Item score 
(%) t
M DI checklist (n =  25)
Cl) Shake the inhaler^: 60
(2) Hold inhaler upright 100
(3) Exhale to residual volume 40
(4) Keep head upright or slighdy tilted 92
(5) Mouthpiece between teeth and lips 68
(6) Inhale slowly and press canistenj: 48
(7) Continue slow and deep inhalation^ 68
C8) Hold breath for five seconds 44
Diskhaler checklist (n = 27)
(1) Perforate blister^ 96
(2) Exhale to residual volume 56^ w
(3) Exhale away from mouthpiece 78
(4) Mouthpiece between teeth and lips 96
(5) Inhale forcefully and deeply^: 100
(6) Hold breath for five seconds 63
(7) Exhale away from mouthpiece 89
(8) Rotate disc 82
Rotahaler checklist (n=68)
( 1 Keep Rotahaler upright}: 63
C 2 Insert Rotacap with transparent end down 96
( 3 Keep Rotahaler horizontal 85
( 4 Rotate both ends to open capsule^ 100
( 5 Exhale to residual volume 34
( 6 Exhale away from mouthpiece 56
( 7 Mouthpiece between teeth and lips 79
( 8 Inhale forcefully and deeply^ 90
( 9 Hold breath for five seconds 46
(10 Exhale away from mouthpiece 79
Turbohaler checklist (n=32)
(1) Keep inhaler upright^: 69
(2) Rotate grip anticlockwise and back until
“click”:}: 100
(3)
9
Exhale to residual volume 34
(4) Exhale away from mouthpiece 50
(5) Mouthpiece between teeth and lips 72
C6) Inhale forcefully and deeply! 94
(7) Hold breath for five seconds 59
(8) Exhale away from mouthpiece 84
• * Percentage of patients performing the checklist item correctly, 
t  Essential checklist items.
Some patients were using more than one in­
haler; in these cases the study was confined to 
one device only. The distribution within the 
patient sample was not uniform so3 in order 
to redress the balance, a descending order of 
preference was established as follows: MDI5 
Diskhaler, Turbohaler, and Rotahaler, All in­
halers were used regularly.
Twelve well trained lung function technicians 
performed all assessments of inhalation tech­
nique, using an inhaler-specific checklist spe­
cially developed for the purpose (table 1). The 
checklists were adapted from those issued by 
the Dutch Asthma Foundation and were tested 
in a pilot study* the results of which have been 
reported elsewhere.12 Each patient was assessed 
by one lung function technician only. Disease 
and inhaler variables were similarly assessed by 
means of a checklist (table 2).
For each inhaler certain items are essential 
for optimal delivery of the active drug into the 
lungs. When errors are made regarding these 
key actions, it is likely that no or only an 
insignificant amount of medicine will be in­
haled. These essential manoeuvres are different 
for the four types of inhalers.
MDIs must be shaken before use in order to 
mix the drug with the propellant (item 1 3 table 
1 ). The patient should inhale slowly (less than 
±  301/min) while simultaneously activating 
the canister (item 6); they should continue to 
inhale slowly throughout discharge (item 7).
In order to use the Diskhaler effectively it is 
necessary to perforate the blister completely 
(item 1 ) and to inhale the powder with sufficient 
inspiratory effort (item 5).
The Rotahaler must be held at an angle of 
less than 45° from the vertical while inserting 
the capsule (item 1). Otherwise, after opening 
the capsule (item 4), the drug may remain 
retained in the opening in the back of the 
inhaler. Patients are then often unable to gen­
erate enough inspiratory force (item 8) to inhale 
the powder. The presence of powder was 
checked by opening the Rotahaler after the 
demonstration by the patient.
The Turbohaler should also be held more or 
less vertically (item 1 ) while rotating the grip 
(item 2) to release the powder for a forceful 
inhalation (item 6).
Educational achievement was divided into 
less than (low) or more than (high) 1 1  years of 
schooling. Similarly, for a history of COPD a 
cutoff point of 10 years was chosen, whereas 
years of experience with the inhaler was divided 
into less than or more than four years.
Approval for the proposed investigation was 
given by the hospital’s ethical committee and 
patients gave informed consent.
STATISTICAL ANALYSIS
Three analyses are presented. The first is based 
on all checklist items (analysis 1 ), the second 
involves a subgroup of selected “essential” 
checklist items only (analysis 2), while the third 
analysis is based on the percentage of patients 
completing all essential items correctly (ana­
lysis 3). The percentage of patients correctly 
completing each item on the checklist was cal­
culated for each of the inhalers (table 1 ).
The total score for each inhaler was cal­
culated by dividing the number of items cor­
rectly completed by the total number of items
Table 2 Patient characteristics
M D I Diskhaler Rotahaler Turbohaler Total Non-participants
No. of patients 
Age
>55 years (p—0*001)*
25 (16%) 27 (19%) 68 (45%) 32 (21%) 152 11
18 (72) 13 (48) 44 (65) 11 (34) 86 (57) 6(55)
< 55  years 7 (28) 14 (52) 24 (35) 21 (66) 66 (43) 5 (45)
Sex (p —NS)*
Men 17 (68) 20 (74) 45 (66) 14 (44) 96 (63) 7 (64)
Women 8 (32) 7(26) 23 (34) 18 (56) 56 (37) 4 (36)
Experience with inhaler
<4 years (p<0-001)* 7 (28) 26 (96) 18 (27) 24 (75) 75 (49) 4 (36)
5=4 years 18 (72) 1 ( 4) 50 (73) 8 (25) 77 (51) 7 (64)
Previous instruction (p = 0-001)*
Yes 20 (80) 26 (96) 44 (65) 30 (94) 120 (79) 5 (83)
No 5(20) 1 ( 4) 24 (35) 2 ( 6) 32 (21) 1 (17)
* y? test.
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Table 3 Inhaler performance
Inhaler No. (%) 
of patients
All items Essential items only
Unadjusted 
mean scored
Adjusted 
mean scorch
Unadjusted 
mean score
Adjusted 
mean score
MDI 25 (16) 65*0 58-5 58*7 61*7
Diskhaler 27 (18) 82*4 71*6 98-2 96-6
Rotahaler 68 (45) 72*8 68*2 84*3 88-3
Turbohaler 32 (21) 70*3 61-3 87*5 88*4
Total 152 72*7 65*7 83*2 85*4
f  Score = percentage of checklist items performed correctly.
:{: Adjusted for educational achievement, type of health care insurance, history of COPDj 
experience with the inhaler, and previous instruction in inhalation technique.
on the checklist and the result was expressed 
as a percentage. A score for the “essential” 
checklist items was similarly arrived at for each 
patient, together with the percentage of patients 
completing all essential items on the list cor­
rectly,
Unadjusted differences in scores among the 
four inhalers were tested with the Kruskall- 
Wallis test. Pairwise comparisons of inhalers 
were made with Wilcoxon’s rank sum test. 
Differences among inhalers regarding discrete 
variables such as age categories, sex* and edu­
cational achievement were tested using the %2 
test or Fisher’s exact test. Differences in scores 
among the four inhalers, adjusted for type of 
health care insurance, educational achieve­
ment, history of COPD, years of experience 
with the inhaler, and previous instruction in 
inhalation technique were assessed using mul­
tiple linear regression analyses. Similarly, ad­
justed differences in dichotomous variables (a 
perfect score on essential checklist items or 
otherwise) among the four inhalers were cal­
culated using logistic regression analyses. The 
limit of statistical significance was set at p =  
005 (two sided), Analyses were performed 
using the statistical package SAS.16
of 15*3 years (range 0-62). They had been 
using their inhaler for an average of 5*1 years 
(range 1 month to 29 years). Table 2 sum­
marises the patient characteristics. Most (86%) 
patients found their inhaler easy to use, ir­
respective of type and manufacturer.
ANALYSIS 1: ALL CHECKLIST ITEMS
Individual item scores for the inhalers are re­
produced in table 1, Mean overall score, inhaler 
specific scores, and differences among inhalers 
based on all checklist items are presented in 
tables 3 and 4. The mean (SD) overall score 
for all items and all inhalers was 72*7 (19-2)%. 
The most frequent errors were “not exhaling 
to residual volume” and “not breath holding 
for five seconds”.
The Diskhaler achieved the best unadjusted 
mean checklist score compared with the other 
inhalers (all p<0'05). After adjustment for edu­
cational achievement, type of health insurance, 
duration of disease, years of experience with the 
inhaler, and previous instruction in inhalation 
technique there were some changes in the 
scores (tables 3 and 4), but the Diskhaler was 
still significantly better than the MDI (13*1%; 
95% confidence interval (Cl) 1-6% to 24*6%) 
and the Turbohaler (10-2%; 95% Cl 0-3% 
to 20*2%), although its superiority over the 
Rotahaler was reduced to 3*4% (95% Cl
— 7*1% to 14-0%).
Patients who had received previous in­
structions in inhalation technique had a 9% 
higher score than those who had not (linear 
regression analysis, p<0-05 for the regression 
coefficient). Similarly, patients with a private 
health care insurance showed a higher ability 
to use an inhaler effectively than those with 
public health care insurance (+10% ,p<0*05).
Results
One hundred and sixty three patients were 
asked to participate in the study. Of these, 11 
refused. There were no apparent differences 
between the data obtained from these non­
participants and those obtained from the par­
ticipants.
Inhalation technique was assessed in 152 
patients with COPD of mean (SD) age 55-1 
(8*7) years, with an average length of history
ANALYSIS 2: ESSENTIAL CHECKLIST ITEMS ONLY
Scores based on essential checklist items are 
reproduced in tables 3 and 4. Taking the un­
adjusted figures first, the mean percentage of 
manoeuvres performed correctly was 83'2%, 
and again there were significant differences 
between the inhalers. As before, the Diskhaler 
gave the best results (all p<0-005) and the 
MDI the poorest (all p<0*001). There was no 
significant difference between die Rotahaler 
and Turbohaler.
Table 4 Diffemtces among inhalers
All items Essential items only
Unadjusted differencef  
(95% Cl)
Adjusted difference$ 
(95% Cl)
Unadjusted difference
(95% Cl)
Adjusted difference 
(95% Cl)
MDI v Turbohaler — 5*3% -2-9% — 28*8% -26*6%
C —16*3 to 5*7) ( -1 3 -2  to 7*5) ( — 41-6 to 15*1) (-38*1 to —15*1)
Diskhaler v Turbohaler + 12*1% + 10-2% 4-10*7% 4-8-2%
(2-0 to 22*2) (0*3 to 20*3) (3*4 to 17*8) (-2*9  to 19*3)
Rotahaler v Turbohaler + 2*5% 4-6*8 -3*2% -0*1%
( — 5*4 to 10*4) (-2 -1  to 15*7) (-11*1 to 4*7) (-10*0  to 9*8)
Diskhaler v MDI 4-17-4% 4-13*1% 4-39*5% 4-34*8%
(6*9 to 27*9) Cl*6 to 24-6) (26*9 to 51*9) (22*0 to 47*6)
Rotahaler v MDI 4-7*8% 4-9-7% 4-25*6% 4-26*5%
(-0*7 to 16-3) (1-0 to 18-4) (14-9 to 36*3) (16*8 to 36*2)
Diskhaler v Rotahaler + 9*6% +  3'4% 4-13*9% 4-8*3%
(1*7 to 17*5) ( —7*1 to 14*0) (6*0 to 21*6) (-3*5  to 20*0)
■ ■ Wilcoxon rank sum test.
t  Adjusted for educational achievement, type of health care insurance, history of COPD, experience with the inhaler, and previous 
instruction in inhalation technique (linear regression analysis).
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Adjusting for patient characteristics altered 
the results. Although the Diskhaler was still 
significantly better than the MDI (34-8%; 95% 
Cl 22-0% to 47*6%), its superiority over both 
the Turbohaler (8-2%; 95% Cl -2*9% to 
19-3%) and the Rotahaler (8-3%; 95% Cl 
— 3-5% to 20*0%)) was less marked.
For essential checklist items only the vari­
ables “previous instruction in inhalation tech­
nique” and “type of health care insurance” had 
no influence on the regression coefficients, but 
there was a tendency among patients who had 
been using their inhaler for more than four 
years to perform worse than those who had 
been using their inhaler for a shorter period 
( — 7%, linear regression analysis, NS).
ANALYSIS 3: ALL ESSENTIAL CHECKLIST ITEMS 
CORRECT
Only 91 patients (59*9%) performed all key 
items correctly (figure). The percentage of 
those who did so with an MDI (24%) was 
significantly lower than for those using the 
oilier three inhalers (all p<0*005). Once again 
the Diskhaler gave the best results, 96-3% of 
patients achieving a 100% score on all key 
manoeuvres, significantly better than the other 
three devices (all p<0*005). There was no sig­
nificant difference between the results for the 
Rotahaler and Turbohaler.
After adjustment for differences in patient 
characteristics, performance with the Diskhaler 
was still significantly better than with the others 
(p<0’05 for both the MDI and Turbohaler) but 
not for the Rotahaler (p = 0*06). The difference 
between patients using the MDI and the Turbo­
haler was not significant, while those using 
the Rotahaler or the Diskhaler did better than 
the MDI users (p<0*005 for both). There was 
no statistically significant difference between 
performances with the Rotahaler and the 
Turbohaler.
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Discussion
How effectively did the patients in the study 
use their inhalers? A 12*1% success rate for all 
items on the checklist, rising to 83*2% when 
only essential actions are considered, suggests 
a generally acceptable inhalation technique. 
Only 60% of patients, however, succeeded in 
performing all essential manoeuvres correctly. 
When one or more errors regarding these key 
actions are made, significant amounts of med­
ication may fail to reach the lungs.
In the present study the inhalation technique 
was evaluated subjectively by a trained lung 
function technician using an inhaler-specific 
checklist. Appel11 has shown that a trained 
observer can achieve a 98% success rate in 
predicting a significant bronchodilator re­
sponse from the subject’s inhalation technique.
The performance of the inhalers differed 
considerably. Of those using the Diskhaler, 
96% were able to perform all essential man­
oeuvres correctly while only 24% of those using 
the MDI managed to do so, Hilton reported 
an even worse performance for the MDI.9 In his 
study the best performer was the Turbohaler, 
while in ours it was the Diskhaler. Hilton ques­
tioned the validity of his results, partly because 
of inequalities in the age distribution of 
his sample, and partly because of a suspicion 
that his scoring system may have favoured the 
Turbohaler.
The Netherlands differs from most other 
countries in that dry power inhalers are the 
most frequently prescribed form of inhaler ther­
apy and there is no evidence that physicians 
prescribe specific inhalers based on patient 
characteristics making selection bias unlikely.
Our study examined whether patient vari­
ables could explain differences in checklist 
scores. Adjustment for education, type of 
health insurance, history of COPD, experience 
with the inhaler, and previous instruction did 
not alter the results much, although the differ­
ences tended to diminish.
In the patient group investigated, age, sex 
and education had no significant effect on the 
ability to use an inhaler correctly, although at 
32-65 years (mean (SD) 55-1 (8-7) with a cut 
off at 65), the age range was somewhat narrow 
and may have influenced the results. In a pre­
vious survey of inhalation technique in 123 
patients with COPD with a mean age of 63i7 
years and no upper age limit, checklist scores 
were lower for all items (68%) and for key 
manoeuvres only (71%),12 suggesting that the 
incidence of errors in inhalation technique does 
tend to increase with age. De Blaquiere et al17 
concluded that the patient’s age and education 
had little influence on correct inhaler use, while 
Appel11 found this to be true for age and sex. 
Appel also reported that older patients were 
less likely to learn to handle an inhaler suc­
cessfully. De Blaquiere et al found that patients 
with the most experience with an inhaler pro­
duced the best results. Neither Appel’s findings 
nor those of our study confirmed this con­
clusion. De Blaquiere et al also stated that 
patients who could recall having had additional 
instruction performed better. In our sample 
this was certainly reflected in the total checklist
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scores but not when key manoeuvres only were 
considered. This could mean that patients re­
member the less important items and forget 
the essential ones, hence the need for stressing 
their relative importance.
As mentioned above, adjusting the figures to 
eliminate variations in patient characteristics 
did reduce the differences between the various 
inhaler scores but did not influence the overall 
result.
One aspect we did not investigate was the 
loading of the Diskhaler. Because manual dex­
terity is required, this might cause problems 
for some patients; this is also true for the 
Rotahaler. For patients with rheumatic arth­
ritis, firing an MDI or twisting the Turbohaler 
grip might also prove difficult.
Although 79% of the patients had had some 
previous instruction in inhalation technique, 
40% of patients performed some key actions 
incorrectly, and in consequence may have re­
ceived little or no drug. This may result in 
prescribing of unnecessarily high doses and 
polypharmacy, generating higher drug costs 
and poorer asthma control.
We conclude that many patients with COPD 
use their inhaler ineffectively. After adjusting 
for patient characteristics, differences among 
inhalers, although less pronounced, persist. 
Fewest errors are made with a Diskhaler, while 
most patients using MDIs make crucial 
mistakes.
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